Halozyme Therapeutics reported $1.86B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
DBV Technologies DBVT:US USD 248.12M 36.86M
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amarin AMRN:US USD 908.3M 64.93M
Amgen AMGN:US USD 65.12B 1.42B
Aptinyx Inc APTX:US USD 76.2M 16.1M
Baxter International BAX:US USD 27.97B 3.87B
Cara Therapeutics CARA:US USD 213.51M 13.06M
Cytokinetics CYTK:US USD 1.08B 304.24M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Immunogen IMGN:US USD 358.8M 63.5M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
Intrexon XON:US USD 259.24M 61.98M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Mannkind MNKD:US USD 293.84M 8.04M
Minerva Neurosciences NERV:US USD 59.76M 5.2M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Peregrine Pharmaceuticals PPHM:US USD 441.85M 9.37M
United Therapeutics UTHR:US USD 5.78B 238.3M
Vanda Pharmaceuticals VNDA:US USD 621.79M 12.69M